| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000035978 |
| Receipt No. | R000040973 |
| Official scientific title of the study | Effect of Sasa powder intake or/and a 60 Hz electric field treatment on sleep quality. |
| Date of disclosure of the study information | 2019/02/22 |
| Last modified on | 2019/02/22 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Effect of Sasa powder intake or/and a 60 Hz electric field treatment on sleep quality. | |
| Title of the study (Brief title) | Effect of Sasa powder intake or/and a 60 Hz electric field treatment on sleep quality. | |
| Region |
|
|
| Condition | ||
| Condition | healthy humans | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Subject to ingest Sasa powder the people who are feeling the lack of sleep, also by comparing the brain waves and subjective symptoms during sleep when were treated with combination a 60 Hz electric field the household potential therapeutic instrument, effect on the improvement of the quality of sleep . |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Brain waves during sleep
|
| Key secondary outcomes | OSA sleep inventory MA version
Visual Analogue Scale |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Oral ingestion of the test food once a day for 4 weeks
Electric potential therapy equipment used for 4 weeks during sleep |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | (1) 40<=Age<64 of healty men and women
(2) Subjects in menopause (3) Subjects with reduced sleep quality (4) Subjects not taking drugs such as sleeping pills (5) Subjects who received a sufficient explanation of the purpose and details of the examination, voluntarily participate in voluntary participation after having a good understanding, understanding well and agreeing to participate in the examination in writing |
|||
| Key exclusion criteria | (1) Subjects with diabetes, liver disease, kidney disease, gastrointestinal disease, peripheral vascular disease, or medical history for severe diseases
(2) Subjects who are diagnosed with heart disease and are restricted from daily extreme exercise (3) Subjects using implantable medical electrical devices (pacemakers, implantable defibrillators, etc.) that are susceptible to electromagnetic interference (4) Subjects using wearable medical electrical devices (electrocardiographs, pacemakers, etc.) (5) Subjects who indicate abnormal parameter in liver or kidney function (6) Subjects with a disease under treatment now (7) Subjects with drug or food allergy (8) Subjects who play high intensity sports or are on a diet (9) Subjects who can not stop taking health foods (including food for specified health uses, foods with function claimss) or designated quasi drugs during the examination period (10) Subjects taking continuous medication (including OTC, prescription drugs) (11) Subjects taking health foods, quasi-drugs, medicines (including OTC, prescription medicine) expected to improve insomnia (12) Subjects using sleep-promoting bedding / equipment (13) Subjects who have used Healthtron or other electric potential therapy devices at present or in the past (14) Subjects who consume excess alcohol or who can not abstain from the day before the test to the day during the sleep brain wave measurement period (15) Subject who has been pregnant or subject who have a plan to become pregnant or breast feed during the study period (16) Subjects who is participating in the other study or planning to participate during the study period (17) Subjects deemed unsuitable by the investigator for other reasons |
|||
| Target sample size | 3 | |||
| Research contact person | |
| Name of lead principal investigator | Naoki Miura |
| Organization | Miura Clinic, Medical Corporation Kanonkai |
| Division name | Internal Medicine |
| Address | Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka, Osaka |
| TEL | 0661355200 |
| mterashima@oneness-sup.co.jp | |
| Public contact | |
| Name of contact person | Makoto Terashima |
| Organization | Oneness Support Co., Ltd. |
| Division name | Clinical Trial Division |
| Address | Higashitenma building 4F, 1-7-17, Higashitenma, Kita-ku, Osaka, Osaka |
| TEL | 0648018917 |
| Homepage URL | |
| mterashima@oneness-sup.co.jp | |
| Sponsor | |
| Institute | Miura Clinic, Medical Corporation Kanonkai |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hakuju Institute for Health Science Co.,Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040973 |